Home
Kopran Ltd Share Price History
Kopran Ltd
NSE : 21 Apr, 2025
200.36-2.2 (-1.1%)
Prev Close
202.6
Open Price
204.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
275646
Today's High / Low
205.5 / 198.0
52 WK High / Low
369.7 / 155.0
Market Price of Kopran Ltd
1M
1Y
3Y
5Y
Monitoring Kopran Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 4.6 |
| YoY Gr. | - |
| Net Profit (Cr.) | 20 |
| BVPS | 28.83 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | 11.34 |
| Net Profit Mgn % | 4.59 |
| Debt to Equity % | 0.97 |
Latest Shareholding
Promoters Holdings Over Time
About Kopran Ltd
- Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises.
- The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment.
- It manufactures semi-synthetic penicillin and is among the world's highest producers in amoxycillin.
- Kopran also makes penicillin-G acylase, an enzyme made through fermentation.
- It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities.
Popular Search
FAQs for Kopran Ltd Share Price History
What are the key events that typically impact Kopran Ltd's share price history?
Key events that impact Kopran Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Kopran Ltd's share price history?
Stock splits reduce the nominal price of Kopran Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Kopran Ltd?
Dividends can influence Kopran Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Kopran Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Kopran Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Kopran Ltd’s share price history?
To understand Kopran Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
